Rachel Norum, NP
Adult Health · Newport News, VANPI 1225505845
Payments from drug & device makers
Across 34 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$127
- Novartis$102
- Servier Pharmaceuticals LLC$78
- Ipsen Biopharmaceuticals, Inc$39
- AstraZeneca$39
- Incyte Corporation$37
- plus $307 from 13 others
What the payments were for
- Food & beverage$729100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $127 |
| Novartis | 4 | $102 |
| Servier Pharmaceuticals LLC | 4 | $78 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| AstraZeneca | 2 | $39 |
| Incyte Corporation | 2 | $37 |
| Pfizer | 1 | $32 |
| Astellas Pharma US Inc | 1 | $32 |
| Seagen Inc. | 1 | $29 |
| Eisai Inc. | 1 | $28 |
| Bayer | 1 | $24 |
| Stryker | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Caris MPI, Inc. | 1 | $22 |
| Novocure Inc. | 1 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Legend Biotech USA Inc. | 1 | $19 |
| Sobi, Inc | 1 | $18 |
| Merck | 1 | $14 |
How this compares
$729 in reported general payments places this provider in the 60th percentile of 368 adult health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 41 | $6,653 |
| Oxycodone Hcl | 139 | $2,209 |
| Midodrine Hcl | 13 | $1,955 |
| Tizanidine Hcl | 16 | $898 |
| Pregabalin | 18 | $781 |
| Mirtazapine | 13 | $508 |
| Azithromycin | 18 | $430 |
| Methadone Hcl | 11 | $344 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $342 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $285 |
| Bumetanide | 13 | $261 |
| Prednisone | 25 | $250 |
| Olanzapine | 14 | $238 |
| Gabapentin | 23 | $236 |
| Hydromorphone Hcl | 16 | $231 |
Paid to pharmacies, not to this prescriber.
Other adult health in Newport News
- Michael FalcoNewport News$6K
- Sandra CorsiNewport News$4K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Chelsea KoskovichFredericksburg$34K
- Brittany BrownLynchburg$14K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.